Mithra Pharmaceuticals SA

ENXTBR:MITRA Rapport sur les actions

Capitalisation boursière : €12.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Mithra Pharmaceuticals Gestion

Gestion contrôle des critères 1/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Christophe Marechal

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général7.6yrs
Propriété du PDGn/a
Durée moyenne d'occupation des postes de direction4.4yrs
Durée moyenne du mandat des membres du conseil d'administration2.8yrs

Mises à jour récentes de la gestion

Recent updates

Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Apr 06
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Feb 07
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

Nov 09
Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Oct 05
These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

May 23
Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Aug 11
Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mar 13
Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Dec 22
Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 24
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

Jun 07
Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

May 10
When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Jan 21
Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 29
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

PDG

Christophe Marechal

7.6yrs

Titularisation

Mr. Christophe Maréchal has been the Chief Financial Officer of Mithra Pharmaceuticals SA since February 23, 2017 and also serves as its Co-Chief Executive Officer since March 5, 2024. Mr. Maréchal serves...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Christophe Marechal
Co-CEO & CFO7.6yrspas de donnéespas de données
Xavier Paoli
COO & Co-CEOless than a yearpas de donnéespas de données
Graham Dixon
Chief Scientific Officer5.2yrspas de donnéespas de données
Alex Sokolowski
Head of Investor Relationsno datapas de donnéespas de données
Fanny Rozenberg
Secretary of the Board & General Counselno datapas de donnéespas de données
Fanny Storms
Compliance Officerno datapas de donnéespas de données
Frederique Depraetere
Communication Directorno datapas de donnéespas de données
Catherine Lejeune
HR Directorno datapas de donnéespas de données
Jean-Manuel Fontaine
Chief Business Officer3.7yrspas de données0.000040%
€ 4.9
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Directorno data€7.12k0.029%
€ 3.6k
Christophe Saillez
Head of Global Regulatory Affairsno datapas de donnéespas de données
Maud Jost
Head of Program & Project Managementno datapas de donnéespas de données

4.4yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de MITRA est considérée comme expérimentée (ancienneté moyenne 4.4 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Director8yrs€7.12k0.029%
€ 3.6k
Jacques Platieau
Independent & Non-Executive Director1.7yrs€25.00kpas de données
Valerie Gordenne
Non-Executive Director2.8yrs€20.00k0.042%
€ 5.1k

2.8yrs

Durée moyenne de l'emploi

Conseil d'administration expérimenté: Le conseil d'administration de la MITRA n'est pas considéré comme expérimenté ( 2.8 années d'ancienneté moyenne), ce qui suggère un nouveau conseil d'administration.